FIELD: medicine. SUBSTANCE: described are new nucleosides with modified sugars of general formula I wherein R1
1
,R1-R5,R1
5
,R1
3
,X,B are as defined in claim 1. Said oligonucleotides with sugar constituent are used as antisense therapeutic agents since they have improved resistance to nucleases and to absorption by cells and retain specificity and affinity to sequence of nucleic acid targets in vitro or in vivo. Also described are oligonucleotides. EFFECT: improved properties of the nucleosides. 21, 63 ex, 14 dwg